Industry News
Medical Device Industry News
MAUI Imaging Emerges From Stealth With $4 Million Department of Defense Contract To Support Trauma Medicine
MAUI Imaging CEO and co-founder David Specht. “The feedback we have received from physicians and technologists highlights the profound need for a new ultrasound-based technology that enables imaging of all types of tissues. That need
PCI Pharma Services In Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
The new ICMRA program is designed to abbreviate the time necessary to receive regulatory approvals from multiple countries. Regulatory agencies from several countries can convene for one inspection as a team, allowing CDMOs such as
Partillion Bioscience Announces Early Access Program for Nanovial Multicell Assays to Enable the Study of Cell-to-Cell Interactions
"Our Nanovial Multicell Assays are a game-changer, opening up new possibilities in research areas where the precise colocalization of cells is essential for studying complex cell-to-cell interactions or screening for therapeutic molecules released by one
XII Medical Raises $45 Mil in Series B Financing
To advance best-in-class neuromodulation therapy for obstructive sleep apnea.
Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer
"This analytical validation study strongly complements EsoGuard's extensive peer-reviewed, published clinical validity and clinical utility evidence base," said Suman Verma, M.D., PhD, Chief Scientific Officer at Lucid Diagnostics. "The results demonstrate very robust analytical performance
Vantedge Medical Completes Acquisition of Hobson & Motzer
The acquisition of Hobson further strengthens Vantedge's position as a nationwide manufacturing partner to blue-chip medical OEMs and broadens Vantedge's consumable portfolio offering. Since Aterian's acquisition of Vantedge in May 2018, Vantedge has acquired five
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Denver
"By partnering with PharmaLogic and offering Neuraceq® in Denver, Life Molecular Imaging is excited to expand access of Neuraceq® for the detection of beta-amyloid plaques in the brain. We believe this additional access benefits physicians
International Consortium to Revolutionize Viral Vector Manufacturing | Reports VVector Bio
"This project represents a paradigm shift towards improving viral vector manufacturing yields," remarked Alina Venereo Sanchez, CEO of VVector Bio. "By integrating genomics, epigenomics, transcriptomics, metabolomics and new ways of directly integrating analytics into production,
Carilion Clinic Further Expands Quality Cardiac Care Access with Latest Philips Innovations at New Regional Cardiovascular Institute in Virginia, US
“At Carilion Clinic, we are committed to improving the health of the communities we serve. We know that collaboration is an essential component to realizing this vision,” said Marguerite Underwood, Vice President for the Carilion
GrayMatters Health Expands Veteran and Civilian Access to FDA-Cleared Prism for PTSD™ Treatment
Home Base, the first and largest private sector brain health clinic in America treating Veterans, Service Members, their Families and Families of the Fallen, is adding Prism as a potential supplementary treatment option to enhance
Qubit Pharmaceuticals nominated for “Best start-up 2024” award by Prix Galien USA
Qubit Pharmaceuticals has been nominated for the 2024 edition of the prestigious Prix Galien USA, in the "Best Startup" category, out of a field of 41 companies, including 15 French contenders.
Providing Safe and Accessible Options for Women’s Reproductive Care
More options, more accessibility, more affordability and a better focus on women’s choices should be everyone’s goal for the medical community by 2030.
Crossject Appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment
Tony Tipton has over 25 years of experience across the key pillars of commercial pharmaceuticals business, encompassing corporate leadership, business development, market access, sales force leadership, marketing and trade operations.
Jung+ Launches Holistic Longevity Program, Offering an Accessible, One-Stop-Shop for the Cutting Edge of Longevity Science
Jung+, a science-backed, human-forward company rewriting the standard approach to longevity care, announces its launch after completing a successful private beta phase with a 10,000-strong community. Founded by Simon Sakhai, a University of Oxford alum
TEPKINLY (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
TEPKINLY is the first and only subcutaneous bispecific antibody approved as a monotherapy in the European Union to treat both relapsed or refractory (R/R) follicular lymphoma (FL) and R/R diffuse large B-cell lymphoma (DLBCL), after
Northwell Health Reports | Receives System-wide Echocardiography Accreditation
“We applaud Northwell Health for achieving accreditation for their 63 locations offering echocardiography services,” said Mary Lally, IAC’s chief executive officer. “The standardization and optimization of echocardiography services leads to reductions in administrative and financial
Guard Medical Announces FDA 510(k) Clearance for Additional Large Sizes of Its Novel NPseal® NPWT Surgical Dressing
“We’re excited to expand our portfolio with the NPseal 20 and NPseal 25. FDA clearance for the additional large sizes allows NPseal to become the dressing of choice for the treatment of closed surgical incisions
ZOLL Announces Successful Bid to Acquire Vyaire Medical
“Respiratory care has been central to ZOLL’s business strategy for many years,” said Jon Rennert, CEO of ZOLL. “If the acquisition is successfully completed, adding Vyaire’s ventilators to ZOLL’s product portfolio will enhance our ability
Dr Kali Stasi Appointed Chief Medical Officer at SalioGen Therapeutics
Most recently, Dr Kali Stasi served as Senior Vice President of Clinical Development at Adverum Biotechnologies.
Real-world Evidence Solutions Market | To be Worth $6.37 Billion by 2031
Clinical evidence obtained from the examination of real-world data (RWD) is known as real-world evidence (RWE).